Delving into the Latest Updates on Laboratório Químico Farmacêutico Bergamo Ltda. with Synapse

Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal Failure

The purpose of this study is to investigate clinical non-inferiority, pharmacodynamic effect and safety of Actparin® (heparin sodium - Laboratório Químico Farmacêutico Bergamo Ltd.) compared to Heparin Sodium (APP Pharmaceuticals) in patients with renal failure under hemodialysis treatment.

开始日期2011-10-01

申办/合作机构

Laboratório Químico Farmacêutico Bergamo Ltda.

[+1]

NCT01180348 / Completed临床3期

Randomized Study of Clinical Non-inferiority of Medicine Botulift (Laboratório Químico Farmacêutico Bergamo Ltd.) Compared to Botox ® (Allergan Inc.) in the Improvement of Wrinkles in the Facial Region.

The dermatological treatment for reducing facial wrinkles with injectable drug Botulift (botulinum toxin type A - Laboratório Químico Farmacêutico BergamoLtd.) has a not inferior activity when compared with Botox ® (botulinum toxin - Allergan Inc.) in clinical trials.

开始日期2011-08-01

申办/合作机构

Azidus Brasil

[+1]

100 项与 Laboratório Químico Farmacêutico Bergamo Ltda. 相关的临床结果

登录后查看更多信息

0 项与 Laboratório Químico Farmacêutico Bergamo Ltda. 相关的专利（医药）

登录后查看更多信息

100 项与 Laboratório Químico Farmacêutico Bergamo Ltda. 相关的药物交易

登录后查看更多信息

100 项与 Laboratório Químico Farmacêutico Bergamo Ltda. 相关的转化医学

登录后查看更多信息